Technetium-99m-labeled melphalan complex and its preparation method and use
A complex and melphalan technology, which is applied in the field of radionuclide-labeled compounds, technetium-99m-labeled melphalan complexes, can solve the problems of no drug activity, etc., and achieve easy-to-obtain raw materials, low cost, and imaging The result is a clear effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0031] (1) Synthesis of DTPA-MFL ligand
[0032] DTPA anhydride (35.7 mg, 0.1 mmol) and melphalan (30.4 mg, 0.1 mmol) were dissolved in 1 mL of DMF, then 20 μL of DIPEA was added, and stirred at room temperature for 1 h; 1 mL of water was added, shaken, filtered, and the filtrate was purified by HPLC. HPLC purification method: Kromasil 100-5C18 purification column (100 × 250mm), the mobile phase is water (phase A) containing 0.1% TFA (trifluoroacetic acid) and methanol (phase B) containing 0.1% TFA, flow rate 3mL / min; t =0, A / B=5 / 5; t=15min, A / B=1 / 9; t=20min, A / B=1 / 9; t=25min, A / B=5 / 5. The fraction with a retention time of 10.3 min was collected and freeze-dried to obtain DTPA-MFL (36.2 mg, 53.2%) as a white powdery solid. ESI-MS: 680.21 (MH + ).
[0033] Preparation of technetium-99m-labeled melphalan complex:
[0034] Dissolve 1 mg of DTPA-MFL ligand in 0.5 mL of water, add 50 μL of SnCl in sequence 2 Solution (1mg / mL, pH=1) and 0.1mL freshly rinsed sodium pertechnetate...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


